logo

For the Inventor, By the Inventor

San Diego, CA, United States of America

Yun Long

LinkedIn

This inventor holds 35 USPTO granted patents and 7 published patent applications and 3 EPO patents, primarily in Cancer Inhibitors. Top assignees: Araxes Pharma LLC, Capella Therapeutics, Inc., Ligand Pharmaceuticals, Inc.. Active years: 2010-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yun Long. Retrieved from https://idiyas.com/inventor/yun-long

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 35 

% Patents Active = 97.1

 

Average Co-Inventor Count = 2.7

ph-index = 13

Forward Citations = 495(Granted Patents)


Company Filing History:

goldMedal24 out of 46 
 
Araxes Pharma LLC
 patents
silverMedal9 out of 9 
 
Capella Therapeutics, Inc.
 patents
bronzeMedal1 out of 139 
 
Ligand Pharmaceuticals, Inc.
 patents
4. 1 out of 3,978 
 
Novartis Ag
 patents

Years Active: 2010-2025

Loading Chart...
Loading Chart...
Areas of Expertise:
KRAS G12C
Benzimidazole
Cancer Treatment
Inhibitors
Quinazoline
Tyrosine Kinase
Pharmaceutical Compositions
Heterocyclic Compounds
Androgen Receptor Modulators
Fused-Tricyclic
EGFR Activity
Substituted Compounds
35 patents (USPTO):Explore Patents
1. RE50490 - Substituted quinazoline compounds and methods of use thereof (2025-07-15),
2. 12234244 - Substituted piperazines as inhibitors of KRAS G12C (2025-02-25),
3. 11878985 - Substituted quinazolines as inhibitors of KRAS G12C (2024-01-23),
4. 11787788 - Benzimidazole derivatives, and pharmaceutical compositions and methods of use thereof (2023-10-17),
5. 11713322 - Benzimidazole derivatives as ERBB tyrosine kinase inhibitors for the treatment of cancer (2023-08-01),
6. 11427565 - Benzimidazoles for use in the treatment of cancer and inflammatory diseases (2022-08-30),
7. 11242352 - Benzimidazole derivatives as ERBB tyrosine kinase inhibitors for the treatment of cancer (2022-02-08),
8. 11021470 - 2-substituted quinazoline compounds comprising a substituted heterocyclic group and methods of use thereof (2021-06-01),
9. 10975071 - Inhibitors of KRAS G12C mutant proteins (2021-04-13),
10. 10927125 - Substituted cinnolines as inhibitors of KRAS G12C (2021-02-23),
11. 10882847 - Inhibitors of KRAS G12C mutant proteins (2021-01-05),
12. 10875842 - Inhibitors of KRAS G12C mutant proteins (2020-12-29),
13. 10858343 - Inhibitors of KRAS G12C mutant proteins (2020-12-08),
14. 10829458 - Substituted quinazoline compounds and methods of use thereof (2020-11-10),
15. 10730867 - Inhibitors of KRAS G12C mutant proteins (2020-08-04),

Title: Inventor Yun Long - Revolutionizing Technology in San Diego

Introduction: Yun Long is a visionary inventor based in San Diego, CA, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Yun Long holds several patents in the areas of artificial intelligence, renewable energy, and biotechnology, showcasing his diverse range of expertise and innovative thinking.

Career Highlights: With a career spanning over two decades, Yun Long has worked with leading tech companies, research institutions, and universities to develop cutting-edge solutions that have had a significant impact on various industries.

Collaborations: Throughout his career, Yun Long has collaborated with top scientists, engineers, and researchers globally, fostering a culture of innovation and knowledge sharing that has led to numerous successful projects and inventions.

Conclusion: Yun Long's passion for pushing the boundaries of technology and his relentless pursuit of innovation continue to inspire the next generation of inventors and entrepreneurs in San Diego and beyond.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…